key: cord-0913840-d8f5rez1
authors: Kim, Jin Il; Park, Sehee; Bae, Joon-Yong; Park, Man-Seong
title: Evolutionary relationship analysis of Middle East respiratory syndrome coronavirus 4a and 4b protein coding sequences
date: 2019-02-19
journal: J Vet Sci
DOI: 10.4142/jvs.2019.20.e1
sha: 18cdd1a1d97483f2cb8a1586b2d4858dab46efa2
doc_id: 913840
cord_uid: d8f5rez1

The 4a and 4b proteins of the Middle East respiratory syndrome coronavirus (MERS-CoV) have been described for their antagonism on host innate immunity. However, unlike clustering patterns of the complete gene sequences of human and camel MERS-CoVs, the 4a and 4b protein coding regions did not constitute species-specific phylogenetic groups. Moreover, given the estimated evolutionary rates of the complete, 4a, and 4b gene sequences, the 4a and 4b proteins might be less affected by species-specific innate immune pressures. These results suggest that the 4a and 4b proteins of MERS-CoV may function against host innate immunity in a manner independent of host species and/or evolutionary clustering patterns.

host innate immunity can be revealed by analysis of the evolutionary relationship of the 4a and 4b genes between human and camel MERS-CoV strains. To this end, we investigated the evolutionary history and rates of MERS-CoV 4a and 4b protein coding regions as well as those of MERS-CoV complete gene sequences using a time-framed Bayesian inference method (BEAST package, v1.10.0; BEAST, New Zealand) [12] with individual settings of molecular clock (for complete gene, lognormal relaxed clock model and for 4a and 4b coding regions, strict clock model), nucleotide substitution (based on the estimated results of best-fit substitution model using jModeltest, v2.1.10: for complete gene, GTR + I + γ; for 4a, TN93 + I; and for 4b, TN93 + γ) [13] , and Markov chain Monte Carlo runs (2 × 10 8 chain length with every 2 × 10 5 iterations after a 10% burn-in). The phylogenetic relationship of MERS-CoV complete gene sequences was reconstructed using a total of 260 sequences (human strains, n = 126 and camel strains, n = 134; sequence sets are available upon request) that were downloaded from the Virus Variation Resource database of National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/genome/viruses/variation/), and their maximum clade credibility trees were visualized using FigTree (v1.4.3; Figtree Systems Pty, Australia). Given the phylogenetic relationship of the complete gene sequences, most camel sequences constituted 5 different genetic groups (camel G1-G5), except for some distantly-related sequences, and the camel G2, G3, and G4 strains appeared to evolve exclusively from human strains. Transmission of MERS-CoV between humans and camels appeared to be identified only in the camel G1 and G5 groups (Fig. 1) .

Unlike the phylogenetic clustering patterns of the complete gene sequences (Fig. 1) , human and camel strains appeared to constitute common genetic groups in the 4a and 4b phylogenetic trees (Fig. 2) . Neither human-specific nor camel-specific clustering patterns were observed in the 4a and 4b phylogenetic trees. Rather, the camel G2, G3, and G4 sequences, which constituted the camel-only phylogenetic groups in the complete gene sequence analysis (Fig. 1) , were mixed with other camel sequences of different phylogenetic groups and with human sequences, and, from camel G1 to G5, all camel sequences were grouped together with human sequences (Fig. 2) . These groupings may imply little or no species-specific antagonism of the human and camel MERS-CoV 4a and 4b proteins against host innate immune responses. Of course, not phylogenetic placements between different host viruses but certain genetic determinants may determine the viral antagonistic mechanism(s) in hosts. The other viral proteins or genetic mutations on the other viral proteins may also compensate for a lack of sufficient viral antagonism [14] . However, results of serological and epidemiological analyses indicate dromedary camels are one of the susceptible hosts of MERS-CoV, even though disease severity of MERS is quite different between humans and camels [1] , and, given that the interaction mechanism(s) between viral surface protein and cellular receptors of hosts may also determine host range restriction [15] , the effects of species-specific viral antagonism on host innate immunity might not be associated with the sustained dissemination of MERS-CoV in humans. Rather, a lack of sufficient viral antagonism of MERS-CoV in humans may be associated with the transmission of the virus from camels to humans, as indicated by the almost 2-fold increased evolutionary rate (1.42 × 10 −3 substitutions/site/year) of the complete gene sequences of human and camel MERS-CoV strains ( Table 1) , compared with the previous study result (0.74 × 10 −3 substitutions/site/year) reported by Kim et al. [3] , which assessed only the human strain sequences. In contrast, the evolutionary rates of the 4a (1. reported by Kim et al. [3] ( Table 1) , which may suggest the absence of large immunemediated pressure differences between human and camel MERS-CoV 4a and 4b proteins and no need for the adaptation of camel MERS-CoV strains prior to zoonotic dissemination to humans. As mentioned above, the effects of other viral proteins and molecular determinants of immune evasion mechanisms of MERS-CoVs on the zoonotic and reverse zoonotic transmission between humans and camels should be investigated further using in vitro and in vivo studies.

In this study, we investigated the evolutionary history and rates of the 4a and 4b protein coding sequences of human and camel MERS-CoV strains. By demonstrating that neither species-specific nor group-specific clustering patterns were observed in the 4a and 4b protein coding regions, we suggest that the antagonistic mechanism of MERS-CoV against host innate immunity might be mediated in a manner independent of host species and/ or evolutionary clustering patterns. Given the disease severity and consequent public health threats of MERS, our results have expanded the knowledge of molecular evolution patterns and virus-host interactions of MERS-CoVs and provide information useful in the development of MERS-CoV vaccines. MERS-CoV, Middle East respiratory syndrome coronavirus; tMRCA, time to the most recent common ancestor; HPD, highest posterior density. *The time of most recent common ancestor; † Lower and upper limits of 95% highest probability density; ‡ Estimation results reported by Kim et al. [3] are indicated in parentheses.

Evolution of MERS-CoV 4a and 4b protein coding sequences Journal of Veterinary Science

WHO MERS Global Summary and Assessment of Risk

World Health Organization. MERS Situation Update [Internet]. World Health Organization; c2018

The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination

Pathogenesis of Middle East respiratory syndrome coronavirus

Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential

Middle East respiratory coronavirus accessory protein 4a inhibits PKRmediated antiviral stress responses

Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response

MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection

Middle East respiratory syndrome coronavirus NS4b protein inhibits host RNase L activation

García-Sastre A. A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses

Role of the B allele of influenza A virus segment 8 in setting mammalian host range and pathogenicity

Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10

jModelTest: phylogenetic model averaging

Specific mutations in the PB2 protein of influenza a virus compensate for the lack of efficient interferon antagonism of the NS1 protein of bat influenza A-like viruses

We appreciate the efforts of all the authors who provided the complete genome sequences of human and camel MERS-CoV strains with the database of National Center for Biotechnology Information (NCBI).